Testing Efruxifermin against a placebo for NASH - nonalcoholic steatohepatitis
Explore this study →
Sites in Toronto, Edmonton and 3 more cities
Official title: A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis · Akero Therapeutics, Inc